Increased CTLA-4(+) T cells and an increased ratio of monocytes with loss of class II (CD14(+) HLA-DR(lo/neg)) found in aggressive pediatric sarcoma patients.

Hingorani, Pooja; Maas, Mary L; Gustafson, Michael P; Dickman, Paul; Adams, Roberta H; Watanabe, Masayo; Eshun, Francis; Williams, James; Seidel, Matthew J; Dietz, Allan B

Hingorani, Pooja; Maas, Mary L; Gustafson, Michael P; Dickman, Paul; Adams, Roberta H; Watanabe, Masayo; Eshun, Francis; Williams, James; Seidel, Matthew J; Dietz, Allan B.

Hingorani P; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ USA.
Maas ML; Human Cellular Therapy Lab, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA.
Gustafson MP; Human Cellular Therapy Lab, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA.
Dickman P; Department of Pathology, Phoenix Children's Hospital, Phoenix, AZ USA.
Adams RH; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ USA.
Watanabe M; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ USA.
Eshun F; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ USA.
Williams J; Center for Cancer and Blood Disorders, Phoenix Children's Hospital, Phoenix, AZ USA.
Seidel MJ; Orthopedic Oncology, Scottsdale, AZ USA.
Dietz AB; Human Cellular Therapy Lab, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First Street SW, Rochester, MN 55905 USA.